
Aflac (AFL) Stock Forecast & Price Target
Aflac (AFL) Analyst Ratings
Bulls say
Aflac is expected to see growth in its Japan segment, which generates the highest revenue for the company, due to the launch of its Anshin Palette medical insurance product and the continued momentum of its Tsumitasu product. The company also aims to increase its cross-selling efforts to drive sales in the Japan market. Furthermore, net investment income increase and focus on maintaining profitability also provide a positive outlook for the company.
Bears say
Aflac is showing signs of struggle in both the US and Japan segments, with lower than expected net earned premiums and a decline in the corporate and other segment. The company's mergers and acquisitions strategy may be a cause for concern as they continue to look for growth opportunities. While the persistency rate in the US remains strong, the company's sales in Japan have been delayed and it is uncertain if they will be able to achieve their goal of $80 billion JPY in sales by 2026.
This aggregate rating is based on analysts' research of Aflac and is not a guaranteed prediction by Public.com or investment advice.
Aflac (AFL) Analyst Forecast & Price Prediction
Start investing in Aflac (AFL)
Order type
Buy in
Order amount
Est. shares
0 shares